Dr. Karam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
Dept Oncology
Saint Louis, MO 63110Phone+1 314-747-7236Fax+1 314-362-8099
Education & Training
MedStar Health/Georgetown University HospitalResidency, Radiation Oncology, 2009 - 2013- MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 2008 - 2009
Georgetown University School of MedicineClass of 2008
Certifications & Licensure
CO State Medical License 2013 - 2025
MO State Medical License 2024 - 2025
DC State Medical License 2008 - 2012- American Board of Radiology Radiation Oncology
Clinical Trials
- Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma Start of enrollment: 2018 Nov 12
- sEphB4-HSA With RT+Chemo or Cetux in Patients With Intermediate to High Risk LAHNSCC Start of enrollment: 2020 Jan 06
Publications & Presentations
PubMed
- Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7immunorad conference.Pierre-Antoine Laurent, Fabrice André, Alexandre Bobard, Desiree Deandreis, Sandra Demaria
Oncoimmunology. 2025-12-01 - MHC class I upregulation contributes to the therapeutic response to radiotherapy in combination with anti-PD-L1/anti-TGF-β in squamous cell carcinomas with enhanced CD...Hanne T Lind, Spencer C Hall, Alexander A Strait, Jack B Goon, John D Aleman
Cancer Letters. 2025-01-01 - Manipulating the EphB4-ephrinB2 axis to reduce metastasis in HNSCC.Khalid N M Abdelazeem, Diemmy Nguyen, Sophia Corbo, Laurel B Darragh, Mike W Matsumoto
Oncogene. 2024-11-03
Journal Articles
- Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients with Oral Cavity CancerDing Ding, Whitney Sumner, David Raben, Mohammad Hararah, Jessica McDermott, Sana D Karam, Julie Goddard, Hilary Somerset, JAMA
- Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck CancerHilary Somerset, Antonio Jimeno, David Raben, Sana D Karam, Dara L Aisner, Madeleine Kane, Carrie Marshall, Daniel W Bowles, Clinical Cancer Research
- Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck CancersSana D Karam, Dallin Milner, Hilary Somerset, Antonio Jimeno, David Raben, Clinical Cancer Research
Press Mentions
Unique Treatment Can Eradicate Pancreatic Tumors While Stopping Cancer ProgressionApril 27th, 2023- Studying the Oral Cancer Immune Landscape in DogsMarch 21st, 2023
- CU Anschutz Researchers Find Less Invasive Treatment for Some Head and Neck CancersNovember 29th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
